Physiologically based toxicokinetic modelling as a tool to support risk assessment: Three case studies

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  Mielke, Hans ^a   Gundert Remy, Ursula ^a,b  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; COUMARIN;

HUMAN; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; TOXICOKINETICS;

EID: 84862274065     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/359471     Document Type: Review

References (56)

1. Teorell T., Kinetics of distribution of substances administered to body Archives Internationales de Pharmacodynamie et de Therapie 1937 57 205 240
2. Dahl S. G., Aarons L., Gundert-Remy U., Karlsson M. O., Schneider Y. J., Steimer J. L., Trocniz I. F., Incorporating physiological and biochemical mechanisms into pharmacokinetic-pharmacodynamic models: a conceptual framework Basic and Clinical Pharmacology and Toxicology 2010 106 1 2 12
3. Mapleton W. W., Chest gas-exchange theory using an electrical analogue Journal of Applied Physiology 1964 19 1193 1199
4. Ashman M. N., Blesser W. B., Epstein R. M., A nonlinear model for the uptake and distribution of halothane in man Anesthesiology 1970 33 4 419 429
5. Poulin P., Theil F. P., Prediction of pharmacokinetics prior to in vivo studiesII. Generic physiologically based pharmacokinetic models of drug disposition Journal of Pharmaceutical Sciences 2002 91 5 1358 1370 (Pubitemid 34651198)
6. IPCS/WHO, Characterization and Application of Physiologically Based Pharmacokinetic models in Risk Assessment. 2010
7. IPCS/WHO, Chemical specific adjustment factors for interspecies differences and intraspecies variability: guidance document for use of data in dose/concentration response assessment. 2005
8. Mielke H., Gundert-Remy U., Bisphenol A levels in blood depend on age and exposure Toxicology Letters 2009 190 1 32 40
9. European Union (EU), Risk Assessment Report 4, 4′ -isopropylidenediphenol (bisphenol-A) CAS No: 80-05-7 EINECS No: 201-245-8 Series 3rd Priority List Volume 2003 37 Office for Official Publications of the European Communities
10. EFSA (European Food Safety Authority), Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) related to 2,2-bis(4-hydroxyphenyl)propane; Question number EFSA-Q-2005-100. 2011, http://www.efsa.europa.eu/en/efsajournal/pub/428.htm
11. vom Saal F. S., Hughes C., An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment Environmental Health Perspectives 2005 113 8 926 933 (Pubitemid 41149619)
12. Zaya M. J., Hines R. N., Stevens J. C., Epirubicin glucuronidation and UGT2B7 developmental expression Drug Metabolism and Disposition 2006 34 12 2097 2101 (Pubitemid 44837771)
13. Ye X., Kuklenyik Z., Needham L. L., Calafat A. M., Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4- methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry Analytical and Bioanalytical Chemistry 2005 383 4 638 644 (Pubitemid 41500595)
14. Kurebayashi H., Okudaira K., Ohno Y., Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans Toxicology Letters 2010 198 2 210 215
15. Abraham K., Mielke H., Huisinga W., Gundert-Remy U., Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration Archives of Toxicology 2005 79 2 63 73 (Pubitemid 40311558)
16. Kuester R. K., Sipes I. G., Prediction of metabolic clearance of bisphenol A (4,4′-dihydroxy-2,2- diphenylpropane) using cryopreserved human hepatocytes Drug Metabolism and Disposition 2007 35 10 1910 1915 (Pubitemid 47481586)
17. Barter Z. E., Bayliss M. K., Beaune P. H., Boobis A. R., Carlile D. J., Edwards R. J., Houston J. B., Lake B. G., Lipscomb J. C., Pelkonen O. R., Tucker G. T., Rostami-Hodjegan A., Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver Current Drug Metabolism 2007 8 1 33 45 (Pubitemid 46043890)
18. Hanioka N., Naito T., Narimatsu S., Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation Chemosphere 2008 74 1 33 36
19. Duanmu Z., Weckle A., Koukouritaki S. B., Hines R. N., Falany J. L., Falany C. N., Kocarek T. A., Runge-Morris M., Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1310 1317 (Pubitemid 43345307)
20. Ginsberg G., Rice D. C., Does rapid metabolism ensure negligible risk from bisphenol A? Environmental Health Perspectives 2009 117 11 1639 1643
21. Nishikawa M., Iwano H., Yanagisawa R., Koike N., Inoue H., Yokota H., Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus Environmental Health Perspectives 2010 118 9 1196 1203
22. Hengstler J. G., Foth H., Gebel T., Cutting edge topics of the current controversy on BPA Critical Reviews in Toxicology 2011 41 263 291
23. EFSA toxicokinetics of bisphenol A The EFSA Journal 2008 759 1 10
24. Mielke H., Partosch F., Gundert-Remy U., The contribution of dermal exposure to the internal exposure of bisphenol A in man Toxicology Letters 2011 204 2-3 190 198
25. Sajiki J., Takahashi K., Yonekubo J., Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography Journal of Chromatography B 1999 736 1-2 255 261
26. Padmanabhan V., Siefert K., Ransom S., Johnson T., Pinkerton J., Anderson L., Tao L., Kannan K., Maternal bisphenol-A levels at delivery: a looming problem? Journal of Perinatology 2008 28 4 258 263 (Pubitemid 351493659)
27. Biedermann S., Tschudin P., Grob K., Transfer of bisphenol A from thermal printer paper to the skin Analytical and Bioanalytical Chemistry 2010 398 1 571 576
28. Mendum T., Stoler E., van Benschoten H., Warner J. C., Concentration of bisphenol A in thermal paper Green Chemistry Letters and Reviews 2011 4 1 81 86
29. stberg T., Noaksson E., Bisfenol A in svenska kvitton. Analysresultat. Institutet fr tillmoa grn kemi. Jmtlands lns Landsting, 2010
30. FAO/WHO Joint FAO/WHO, Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A. Summary Report, 2010
31. Tyl R. W., Myers C. B., Marr M. C., Thomas B. F., Keimowitz A. R., Brine D. R., Veselica M. M., Fail P. A., Chang T. Y., Seely J. C., Joiner R. L., Butala J. H., Dimond S. S., Cagen S. Z., Shiotsuka R. N., Stropp G. D., Waechter J. M., Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats Toxicological Sciences 2002 68 1 121 146 (Pubitemid 34785236)
32. Mrck T. J., Sorda G., Bechi N., Rasmussen B. S., Nielsen J. B., Ietta F., Rytting E., Mathiesen L., Paulesu L., Knudsen L. E., Placental transport and in vitro effects of Bisphenol A Reproductive Toxicology 2010 30 1 131 137
33. Zalko D., Jacques C., Duplan H., Bruel S., Perdu E., Viable skin efficiently absorbs and metabolizes bisphenol A Chemosphere 2011 82 3 424 430
34. Tsukioka T., Terasawa J., Sato S., Hatayama Y., Makino T., Nakazawa H., Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA Journal of Environmental Chemistry 2004 14 57 63
35. Teeguarden J. G., Calafat A. M., Ye X., Doerge D. R., Churchwell M. I., Gunawan R., Graham M. K., Twenty-four hour human urine and serum profiles of bisphenol A during high-dietary exposure Toxicological Sciences 2011 123 1 48 57
36. Calafat A. M., Weuve J., Ye X., Jia L. T., Hu H., Ringer S., Huttner K., Hauser R., Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants Environmental Health Perspectives 2009 117 4 639 644
37. Mielke H., Abraham K., Gtz M., Vieth B., Lampen A., Luch A., Gundert-Remy U., Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolationthe case of coumarin Toxicology Letters 2011 202 2 100 110
38. EFSA (European Food Safety Authority), Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to Coumarin The EFSA Journal 2004 104 1 136
39. Umbach W., Kosmetik von Kopf bis Fuss 2004 3rd Weinheim, Germany Wiley-VCH
40. Inspectorate of the German States. Internal Report, 2005
41. Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP), Opinion concerning 6-Acetyl-1,1,2,4,4,7- Hexamethyltetryltetralin (AHTN) SCCNFP/0609/02. 2002
42. Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP), Opinion concerning Hexahydrohexamethyl-cyclopenta ()-2-benzopyran (HHCB) SCCNFP/0610/02. 2002
43. Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP), Note for Guidance for testing of cosmetic ingredients and their safety evaluation. 5th revision, 2003
44. Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers (SCCNFP), 2004, Opinion concerning musk xylene and musk keton, SCCNFP/0817/04. Scientific Committee on Consumer Products (SCCP). Note for Guidance for testing of cosmetic ingredients and their safety evaluation. 6th revision, 2006
45. Scientific Committee on Food (SCF),. Opinion on coumarin (a constituent of natural flavouring source materials limited by Annex II of flavourings directive 88/388/EEC), expressed on 16 December 1994. Reports of the Scientific Committee on Food (36th series). European Commission, Directorate General Industry. Luxembourg, 1997
46. Beckley-Kartey S. A. J., Hotchkiss S. A. M., Capel M., Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse Toxicology and Applied Pharmacology 1997 145 1 34 42 (Pubitemid 27294767)
47. Ford R. A., Hawkins D. R., Mayo B. C., Api A. M., The in vivo dermal absorption and metabolism of [4- 14 C]coumarin by rats and by human volunteers under simulated conditions of use in fragrances Food and Chemical Toxicology 2001 39 2 153 162 (Pubitemid 32239354)
48. BfR (Bundesinstitut fuer Risikobewertung). Kosmetika knnen wesentlich zur Gesamtaufnahme von Cumarin beitragen. (BfR Nr. 049/2007), 2007, http://www.bfr.bund.de/cm/206/ kosmetikakoennenwesentlichzurgesamtaufnahmevoncumarinbeitragen.pdf
49. Ritschel W. A., Hoffmann K. A., Tan H. S., Sanders P. R., Pharmacokinetics of coumarin upon i.v. administration in man Drug Research 1976 26 7 1382 1387
50. Ritschel W. A., Brady M. E., Tan H. S.I., Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man European Journal of Clinical Pharmacology 1977 12 6 457 461 (Pubitemid 8253620)
51. Ritschel W. A., Brady M. E., Tan H. S. I., First-pass effect of coumarin in man International Journal of Clinical Pharmacology Therapy and Toxicology 1979 17 3 99 103 (Pubitemid 9122609)
52. Ritschel W. A., Hussain S. A., Transdermal absorption and topical availability of coumarin Methods Findings in Experimental Clinical Pharmacology 1988 10 165 169
53. Rietjens I. M. C. M., Boersma M. G., Zaleska M., Punt A., Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling Toxicology in Vitro 2008 22 8 1890 1901
54. Loizou G., Spendiff M., Barton H. A., Bessems J., Bois F. Y., d'Yvoire M. B., Buist H., Clewell III H. J., Meek B., Gundert-Remy U., Goerlitz G., Schmitt W., Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps Regulatory Toxicology and Pharmacology 2008 50 3 400 411
55. Barton H. A., Chiu W. A., Woodrow Setzer R., Andersen M. E., Bailer A. J., Bois F. Y., Dewoskin R. S., Hays S., Johanson G., Jones N., Loizou G., Macphail R. C., Portier C. J., Spendiff M., Tan Y. M., Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation Toxicological Sciences 2007 99 2 395 402 (Pubitemid 351753057)
56. Weie A. Y., Huisinga W., Error-controlled global sensitivity analysis of ordinary differential equations Journal of Computational Physics 2011 230 17 6824 6842